Abstract:Objectives: We hypothesized that angiotensin-converting enzyme 2 (ACE2) deficiency would facilitate angiotensin (Ang) II-mediated vascular inflammation and the actin-binding protein profilin-1 signaling. Design and methods: We randomized 10-week ACE2 knockout (ACE2KO, Ace2–/y) and wild-type littermates (WT, Ace2+/y) mice to Ang II (1.5 mg.kg−1.d−1) infusion with mini-osmotic pumps and treated daily with irbesartan (50 mg/kg) for 2 weeks. Results: Aortic ACE2 protein was obviously reduced in WT mice in response to Ang II related to increases in profilin-1 protein. Loss of ACE2 resulted in greater increases in Ang II-induced mRNA expressions of inflammatory cytokines MCP-1, IL-1β, and IL-6 in aortas of ACE2KO mice, along with enhanced profilin-1 expression and phosphorylated ERK1/2 levels. Interestingly, irbesartan significantly attenuated Ang II-mediated aortic inflammation in WT mice with enhanced ACE2 levels and suppression of the profilin-1/ERK signaling. Conclusions: Our findings reveal that ACE2 deficiency worsens Ang II-mediated aortic inflammation and profilin-1 signaling, suggesting a potential therapeutic approach by enhancing ACE2 action for patients with vascular diseases. Supported by National Natural Science Foundation of China (30973522&81170246), Shanghai Pujiang Talents Program (11PJ1408300), and CIHR (86602&84279).

1040 ANGIOTENSIN II-MEDIATED VASCULAR INFLAMMATION IS ACCELERATED IN ACE2 NULL MICE WITH ENHANCED PROFILIN-1 EXPRESSION